Enanta Pharmaceuticals
ENTA
#8440
Rank
$0.16 B
Marketcap
$7.78
Share price
-1.27%
Change (1 day)
-45.59%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of March 2025 (TTM): 2.51

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.49. At the end of 2024 the company had a P/S ratio of 1.91.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.91-28.93%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
6.43 156.53%๐Ÿ‡บ๐Ÿ‡ธ USA
4.42 76.31%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1 343.36%๐Ÿ‡บ๐Ÿ‡ธ USA
3.63 44.93%๐Ÿ‡บ๐Ÿ‡ธ USA
2.47-1.52%๐Ÿ‡บ๐Ÿ‡ธ USA
4.13 64.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland